If any patient is concerned about their treatment, they should discuss this with their clinician. In March this year, NICE recommended a weekly injection of semaglutide, manufactured by Novo Nordisk under the brand name Wegovy, for adults who have at least one weight-related comorbidity and a body mass index (BMI) of at least 35kg/m2
Explore GLP-1 medication options, the GLP-1 weight loss program, tirzepatide medication options, or the tirzepatide weight loss program
They must use sterile equipment, properly dispose of used needles, and label samples accurately to avoid errors
Structure Therapeutic's GSBR-1290 - another oral competitor Another competitor focusing on a white pill for GLP-1 is Structure with their drug GSBR-1290
Major cardiovascular upgrade
We accept insurance, manage prior authorizations, and offer continuous care coordination, so you can focus on your health goals